Category: Prescription Drugs
Prescription Drugs market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Fibromyalgia Therapeutics
The 2025-2030 World Outlook for Fibromyalgia Therapeutics This study covers the world outlook for fibromyalgia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for First Generation Antipsychotic Drugs for Schizophrenia
The 2025-2030 World Outlook for First Generation Antipsychotic Drugs for Schizophrenia This study covers the world outlook for first generation antipsychotic drugs for schizophrenia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema
The 2025-2030 World Outlook for Hereditary Angioedema This study covers the world outlook for hereditary angioedema across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Non-Infectious Macular Edema Treatments
The 2025-2030 World Outlook for Non-Infectious Macular Edema Treatments This study covers the world outlook for non-infectious macular Edema treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Lipid Disorder Treatments
The 2025-2030 World Outlook for Lipid Disorder Treatments This study covers the world outlook for lipid disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Macular Degeneration Treatments
The 2025-2030 World Outlook for Macular Degeneration Treatments This study covers the world outlook for macular degeneration treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases Treatments
The 2025-2030 World Outlook for Neurodegenerative Diseases Treatments This study covers the world outlook for neurodegenerative diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Tamiflu (Oseltamivir Phosphate)
The 2025-2030 World Outlook for Tamiflu (Oseltamivir Phosphate) This study covers the world outlook for tamiflu (oseltamivir phosphate) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Idiopathic Inflammatory Myopathy Treatments
The 2025-2030 World Outlook for Idiopathic Inflammatory Myopathy Treatments This study covers the world outlook for idiopathic inflammatory myopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments
The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments This study covers the world outlook for neuroendocrine tumor treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Allergy Drugs
The 2025-2030 World Outlook for Allergy Drugs This study covers the world outlook for allergy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Human Growth Hormone Drugs
The 2025-2030 World Outlook for Human Growth Hormone Drugs This study covers the world outlook for human growth hormone drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Bioidentical Hormones
The 2025-2030 World Outlook for Bioidentical Hormones This study covers the world outlook for bioidentical hormones across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Diseases
The 2025-2030 World Outlook for Alzheimer's Diseases This study covers the world outlook for Alzheimer's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Analgesics (Painkillers)
The 2025-2030 World Outlook for Analgesics (Painkillers) This study covers the world outlook for analgesics (painkillers) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cognitive and Memory Enhancer Drugs
The 2025-2030 World Outlook for Cognitive and Memory Enhancer Drugs This study covers the world outlook for cognitive and memory enhancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis
The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis This study covers the world outlook for drugs for rheumatoid arthritis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Hospital Acquired Infection Treatments
The 2025-2030 World Outlook for Hospital Acquired Infection Treatments This study covers the world outlook for hospital acquired infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Hospital Acquired Infections Testing
The 2025-2030 World Outlook for Hospital Acquired Infections Testing This study covers the world outlook for hospital acquired infections testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Digital Pills
The 2025-2030 World Outlook for Digital Pills This study covers the world outlook for digital pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Pharmacy Automation Systems
The 2025-2030 World Outlook for Pharmacy Automation Systems This study covers the world outlook for pharmacy automation systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Glioblastoma Multiforme Drugs
The 2025-2030 World Outlook for Glioblastoma Multiforme Drugs This study covers the world outlook for glioblastoma multiforme drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Anti-Migraine Drugs
The 2025-2030 World Outlook for Anti-Migraine Drugs This study covers the world outlook for anti-migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Hunter Syndrome Treatments
The 2025-2030 World Outlook for Hunter Syndrome Treatments This study covers the world outlook for Hunter syndrome treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
Research Assistance
